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Abstract
Background: The blood-brain barrier (BBB) plays the crucial role of limiting exposure of the central nervous system
(CNS) to damaging molecules and cells. Dysfunction of the BBB is critical in a broad range of CNS disorders
including neurodegeneration, inflammatory or traumatic injury to the CNS, and stroke. In peripheral tissues, the
vascular-tissue permeability is normally greater than BBB permeability, but vascular leakage can be induced by
efferent discharge activity in primary sensory neurons leading to plasma extravasation into the extravascular space.
Whether discharge activity of sensory afferents entering the CNS may open the BBB or blood-spinal cord barrier
(BSCB) remains an open question.
Results: Here we show that peripheral nerve injury (PNI) produced by either sciatic nerve constriction or transecting
two of its main branches causes an increase in BSCB permeability, as assessed by using Evans Blue dye or horseradish
peroxidase. The increase in BSCB permeability was not observed 6 hours after the PNI but was apparent 24 hours after
the injury. The increase in BSCB permeability was transient, peaking about 24-48 hrs after PNI with BSCB integrity
returning to normal levels by 7 days. The increase in BSCB permeability was prevented by administering the local
anaesthetic lidocaine at the site of the nerve injury. BSCB permeability was also increased 24 hours after electrical
stimulation of the sciatic nerve at intensity sufficient to activate C-fibers, but not when A-fibers only were activated.
Likewise, BSCB permeability increased following application of capsaicin to the nerve. The increase in permeability
caused by C-fiber stimulation or by PNI was not anatomically limited to the site of central termination of primary
afferents from the sciatic nerve in the lumbar cord, but rather extended throughout the spinal cord and into the brain.
Conclusions: We have discovered that injury to a peripheral nerve and electrical stimulation of C-fibers each cause
an increase in the permeability of the BSCB and the BBB. The increase in permeability is delayed in onset, peaks at
about 24 hours and is dependent upon action potential propagation. As the increase is mimicked by applying
capsaicin to the nerve, the most parsimonious explanation for our findings is that the increase in permeability is
mediated by activation of TRPV1-expressing primary sensory neurons. Our findings may be relevant to the
development of pain and neuroplastic changes in the CNS following nerve injury. In addition, our findings may
provide the basis for developing methods to purposefully open the BBB when needed to increase brain
penetration of therapeutic agents that might normally be excluded by an intact BBB.
Background
The blood-brain barrier (BBB) is a highly specialized
structure crucial for the maintenance of central nervous
system (CNS) homeostasis [1,2]. The basis of the barrier
in the brain, and the corresponding barrier in the spinal
cord - the blood-spinal cord barrier (BSCB), is a net-
work of endothelial cells joined by tight junctions that
line the blood vessels within the CNS [3,4]. The core
‘neurovascular unit’ comprises endothelial cells, peri-
cytes and astrocytic endfeet embedded within their basal
laminae. The space between the astrocytic endfeet,
which make up the abluminal surface of CNS capillaries,
and the endothelial cells/pericytes represents the inter-
face between the blood and CNS. The BBB is highly
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diffusible molecules readily crossing from the blood into
the CNS parenchyma. Thus, most substances are nor-
mally precluded from entering the CNS by the BBB.
However, in many CNS pathological states the BBB
becomes disrupted, allowing entry of substances from
blood into the CNS, and this disruption is considered a
key step for disorders such as traumatic injury, stroke
and neurodegeneration.
In peripheral tissues, vascular permeability is normally
greater than in the CNS, although there is a vascular-
tissue barrier that excludes, for example, large proteins
from entering the tissue. It has long been known that
peripheral vascular permeability in skin and other tis-
sues can be markedly increased by antidromic dis-
charges in primary sensory neurons, allowing large
proteins to leak through capillaries thereby causing
plasma extravasation [5-7]. This plasma extravasation,
together with the vasodilation that is produced by sen-
sory nerve stimulation, comprise neurogenic inflamma-
tion which is mediated by the release of the peptides
substance P and calcitonin gene-related peptide (CGRP)
from peripheral terminals of peptidergic C-fibers [6,8,9].
In accordance with Dale’s Principle [10], discharge
activity in peptidergic C-fibers also releases substance P
and CGRP from the central terminals of primary affer-
ents in the spinal cord dorsal horn [11,12]. However, it
has been found that vascular permeability in the dorsal
horn is not increased by activating C-fibers, at least
over the time course of peripheral neurogenic inflam-
mation [13]. Therefore, it has been assumed that
although activity in sensory nerves causes rapid
increases in vascular permeability in peripheral tissues,
this activity is not capable of causing vascular perme-
ability to increase in the CNS.
Discharge activity in primary afferents, particularly
that initiated by injury to sensory nerves, may have
slowly developing and persistent consequences in the
nervous system that can lead to chronic pain states [14].
Emerging evidence indicates that one such consequence
of peripheral nerve injury (PNI) is the entry of mono-
cytes [15] and T cells [16,17] from the circulation into
the spinal dorsal horn. Because the accumulation of
these normally circulating cells is apparent many hours
or days after the nerve injury, we wondered whether the
BSCB may be disrupted at these times, as has been sug-
gested at longer times after spinal nerve transection
[18]. Therefore, here we investigated whether PNI or
activation of primary afferent C-fibers may cause
increased vascular permeability in the CNS but over a
time course beyond that of neurogenic inflammation.
Preliminary results of portions of this work have been
reported [19].
Results
Peripheral nerve injury causes delayed opening of the
blood-spinal cord barrier
BSCB permeability is increased by chronic constriction
injury (CCI)
We assessed the integrity of the BSCB with intrave-
nously administered Evans Blue dye. Evans Blue binds
to albumin in the circulation producing a molecular
complex of sufficient molecular size that it does not
cross the intact BSCB or BBB. Thus, there is minimal
accumulation of Evans Blue in the spinal cord, or
brain, under basal conditions in naïve animals (Figure
1). To investigate whether BSCB permeability might be
altered by CCI we administered Evans Blue at varying
times after the nerve injury, induced by placing a poly-
thene cuff around the nerve, and quantified the
amount of Evans Blue in the dorsal spinal cord ipsilat-
eral to the injury. We found that 6 hours after the CCI
surgery, the level of Evans Blue accumulating was not
d i f f e r e n tf r o mt h a to ft h ed o r s a lh o r no fn a ï v ea n i m a l s ,
or animals that we subjected to sham surgery (Figure
1A left). In contrast, 24 hours after surgery there was a
significant increase in Evans Blue in the ipsilateral dor-
sal horn of nerve-injured animals as compared with
sham controls (Figure 1A left). Evans Blue accumula-
tion in the dorsal horn of nerve-injured animals was
also significantly increased when the dye was adminis-
tered 3 days after surgery. However, when Evans Blue
was administered 7 days after surgery the dye accumu-
lation in the dorsal horn of nerve-injured animals was
not different from that of sham controls or naïve
animals.
To independently assess the status of the BSCB we
intravenously administered horse radishperoxidase
(HRP) which, like Evans Blue bound to albumin, is
not able to cross the normal intact BSCB. We found
that HRP coats the lining of vessels but does not enter
the parenchyma of the dorsal horn after intravenous
injection in naïve animals (Figure 1B). However, when
administered at 24 hours after CCI, HRP was readily
visualized in the dorsal horn parenchyma. By quantify-
ing HRP in the ipsilateral dorsal horn we found that
the amount of HRP was significantly increased in the
dorsal horn from nerve-injured animals as compared
with that from control animals (Figure 1B). From the
accumulation of HRP and of Evans Blue after nerve
injury we conclude that the permeability of the BSCB
increases after CCI. The increase in BSCB permeabil-
ity is delayed by more than 6 hours and appears to
peak about after 24 hours after the surgery. The
increase in permeability is transient, with BSCB per-
meability returning to control levels by 7 days after
CCI surgery.
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permeability
To determine whether the increase in BSCB permeability
was a unique consequence of CCI or whether increased
permeability may be induced by other types of nerve
injury, we examined the effects of axotomy of the sciatic
nerve, in which the common peroneal and tibial nerves
were transected. We found that 24 hours and 3 days after
surgery Evans Blue accumulation in the dorsal horn was
significantly increased in animals with SNI compared with
Figure 1 Peripheral nerve injury (PNI) increases BSCB permeability. A: Increased permeability to Evans Blue of spinal cord from naïve rats,
sham operated rats or rats with chronic constriction injury (CCI, left) or spared nerve injury (SNI, right). Inset: Standard curve of Evans blue and
the representative reading of naïve rats or CCI rats. B: Increased permeability to horseradish peroxidase (HRP) following PNI. Left, representative
spinal cord sections of HRP extravasation 24 hours after SNI, CCI or naïve rats. Right, histogram showing the integrated pixel density of HRP
signaling. Data are presented as mean ± SEM; *p < 0.05 compared to naïve; n = 4-6 per group. All measurements are from lumbar spinal cord
ipsilateral to PNI stimulation.
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(Figure 1A right). There was no increase in Evans Blue
accumulation 6 hours or 7 days after SNI. In addition,
HRP was found to accumulate in the dorsal horn parench-
yma when assessed at 24 hours after SNI (Figure 1B).
Thus, we conclude that, like CCI, SNI causes a delayed
and transient increase in BSCB permeability, and therefore
that increased BSCB permeability may be a general conse-
quence of injury to a peripheral nerve. Because the magni-
tude and time course of the increase in Evans Blue and
HRP accumulation were similar for CCI and SNI we used
only one nerve injury model, CCI, and one approach to
assess BSCB permeability, Evans Blue administration, for
the remainder of the present study.
CCI-induced increase in BSCB permeability is prevented by
lidocaine
To determine whether opening of the BSCB requires pro-
pagation of action potentials from the site of nerve injury,
we investigated the effect of the local anaesthetic lidocaine.
Lidocaine was applied directly to the nerves starting 30
min prior to injury to ensure that action potentials were
blocked at the time of nerve transection. Gel foam soaked
in lidocaine was placed around the nerves after transection
and we administered Evans Blue 24 hours later. We found
that administering lidocaine prevented the increase in
Evans Blue accumulation after CCI (Figure 2A). From this
finding we infer that action potential propagation in the
transected nerves is required to cause the increase in
BSCB opening after peripheral nerve injury.
Recovery of BSCB integrity after CCI due to loss of signal to
open
The increase in BSCB permeability was transient with per-
meability returning to control levels by 7 days after nerve
injury. We reasoned that the recovery of BSCB integrity
might be due to loss of a drive that sustains BSCB opening
or that the BSCB might become resistant to the driving
signals. To differentiate between these possibilities we
made a second nerve injury, on the side contralateral to
the first injury, 6 days after the first injury. We found that
there was a significant increase in Evans Blue accumula-
tion in the dorsal spinal cord 24 hrs after the second nerve
injury (Figure 2B). Thus, the BSCB was not resistant to
opening when a drive to open was presented on day 6.
Therefore, we conclude that the recovery of BSCB perme-
ability was due to a recovery of the action potential-depen-
dent drive to open after the nerve injury.
Short-duration stimulation of C-fibers opens BSCB
C-fiber but not A-fiber stimulation causes increase in BSCB
permeability
In order to determine which type of peripheral nerve
fiber may drive opening of the BSCB, we made use of
electrical stimulation of the intact sciatic nerve to differ-
entially activate different classes of peripheral nerve
fibers. As electrical stimulation for only several minutes
in duration can produce peripheral vasodilation and
plasma extravasation [20], and can induce long-lasting
pain hypersensitivity [21], we examined effects of short-
duration stimulation on Evans Blue accumulation in the
ipsilateral dorsal spinal cord. We found that electrical
Figure 2 The effect of local lidocaine block and sequential nerve
injury on CCI-induced increase in BSCB permeability.A :2 %o f
Lidocaine was applied to the sciatic nerve immediately following
CCI, and Evans Blue extravasation in the ipsilateral lumbar spinal
cord was measured 24 hours post CCI. B: A sequential CCI was
performed on the right sciatic nerve after the initial CCI was
performed in the left sciatic nerve 6 days previously. Evans blue
extravasation was measured 7 days after initial CCI. All readings are
from the left lumbar spinal cords (ipsilateral to the initial injury).
Data are presented as mean ± SEM; *p < 0.05 **p < 0.01 compared
to naïve; n = 5 per group.
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Hz; 5 min) caused no change in Evans Blue accumula-
tion (Figure 3A). By contrast, stimulation sufficient to
recruit primary afferent C-fibers (10 mA; 10 Hz; 5 min)
caused a delayed increase in Evans Blue accumulation:
Evans Blue was not different from control 3 hrs after C-
fiber stimulation (not illustrated), but was significantly
increased 24 hrs after stimulation (Figure 3A). Electrical
stimulation at C-fiber intensities also produced an
increase in HRP in the ipsilateral dorsal spinal cord 24
hrs after the stimulation (Figure 3B). Thus, the short-
duration electrical stimulation of C-fibers but not A-
fibers was sufficient to cause a delayed increase in BSCB
permeability.
Increase in BSCB permeability by C-fiber stimulation is
blocked by lidocaine
It is conceivable that short duration C-fiber stimulation
initiates long-lasting discharge in primary afferents and
to investigate this possibility we applied lidocaine to the
sciatic nerve either before or immediately after the elec-
trical stimulation. We found that applying lidocaine
prior to the stimulation prevented the increase in Evans
Blue accumulation 24 hrs later (Figure 3C). In contrast,
applying lidocaine immediately after the electrical stimu-
lation had no effect on the Evans Blue accumulation at
24 hrs. Under the conditions used, blockade of action
potential propagation develops within 15-20 minutes
and therefore we conclude the C-fiber discharge during
the electrical stimulation, and possibly in the immediate
few minutes thereafter, acts as a trigger to cause the
delayed increase in BSCB permeability.
Capsaicin applied to the sciatic nerve causes increased
BSCB permeability at 24 hrs
Neurogenic plasma extravasation is mediated through
activating primary afferent C-fibers that express TRPV1
and are hence activated by capsaicin [9,22]. To deter-
mine whether activating this class of primary afferent
might increase BSCB permeability we applied capsaicin
to the sciatic nerve and measured Evans Blue in the dor-
sal spinal cord 24 hrs later. We found that capsaicin, but
not vehicle control, caused an increase in Evans Blue at
24 hrs (Figure 4A). In contrast applying capsaicin to the
sciatic nerve led to peripheral plasma extravasation that
was apparent within 45 min (Figure 4B) Thus, we con-
clude that activating TRPV1-expressing C-fibers is suffi-
cient to cause an increase in BSCB permeability.
C-fiber stimulation and peripheral nerve injury cause
delayed widespread opening of BSCB
Sciatic nerve C-fiber stimulation causes increase in BSCB
permeability in spinal cord
In investigating the effects of electrical C-fiber stimula-
tion we examined the contralateral as well as the ipsi-
lateral lumbar dorsal spinal cord and found that the
increase in Evans Blue accumulation 24 hrs after sti-
mulation was produced in the contralateral, as well as
the ipsilateral dorsal spinal cord (Figure 5A). Moreover
the level of Evans Blue in the contralateral side was
not different from on the side ipsilateral to the nerve
stimulation. Increased Evans Blue accumulation in the
contralateral dorsal cord was mimicked by applying
capsaicin to the sciatic nerve (Figure 5A). The
increases in Evans Blue accumulation in spinal cord
was prevented by applying lidocaine to the sciatic
nerve just prior to electrical stimulation (Figure 5A).
Figure 3 C-fiber intensity stimulation increases BSCB
permeability. A: Sciatic nerve stimulation with C-fiber intensity, but
not A-fiber intensity increases permeability to Evans Blue in rat
spinal cord 24 hours post stimulation. Data are presented as mean
± SEM; **p < 0.01 compared to naïve, n = 4-8 per group. B:
Representative spinal cord sections of HRP extravasation from naïve
rats or rats 24 hours post C-fiber intensity stimulation of the sciatic
nerve. C: C-fiber intensity stimulation-induced permeability is
blocked by pre-treatment, but not post-treatment, with lidocaine.
2% lidocaine was applied to the sciatic nerve either 30 minutes
before C-fiber stimulation (pre-block) or immediately after C-fiber
stimulation (post-block). The duration of lidocaine treatment was 30
minutes in both cases. Data are presented as mean ± SEM; **p <
0.01 compared to C-fiber stimulation, n = 4-8 per group. All the
readings are from lumbar spinal cord ipsilateral to nerve stimulation.
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increase in BSCB permeability triggered by short-dura-
tion electrical stimulation of C-fibers was not restricted
to the ipisilateral spinal dorsal horn but was wide-
spread in the spinal cord.
PNI causes increase in BSCB and BBB permeability in
thoracic and cervical spinal cord and in brain
We therefore questioned whether PNI might also cause
widespread opening of the blood-CNS barriers. We
found that Evans Blue accumulation was significantly
increased throughout the spinal cord 24 hrs after CCI
and SNI (Figure 5B). Thus, like C-fiber stimulation,
injury to a peripheral nerve causes extensive opening of
the BSCB. In addition, we measured Evans Blue accu-
mulation in brain regions following CCI. Significant
increases were found in caudal brain regions; brain stem
Evans Blue levels were significantly increased at 3 days
post CCI (p < 0.05). Progressively more rostral brain
areas showed lower levels of Evans Blue accumulation;
occipital cortex p = 0.058; cerebellum and frontal cortex
showed no significant increase. Thus, in addition to
increasing BSCB permeability, PNI causes disruption of
the BBB in some regions of the brain.
Discussion
Here we have discovered that peripheral nerve injury or
electrical stimulation of C-fibers in the sciatic nerve pro-
duce opening of the blood-spinal cord and blood-brain
barriers. The increase in BSCB permeability is prevented
by applying lidocaine to the nerve prior to the nerve
injury or electrical stimulation, indicating that action
potential discharge is required. By contrast, applying
lidocaine directly after the electrical stimulation had no
effect on the subsequent increase in BSCB permeability.
Figure 4 Local application of capsaicin increases BSCB permeability. A: 1% Capsaicin or vehicle was applied onto the sciatic nerve and Evans
Blue extravasation was measured 24 hours later. All readings are from lumbar spinal cord ipsilateral to capsaicin or vehicle. Data are presented
as mean ± SEM; **p < 0.01 compared to naïve, n = 5-9 per group. B: 1% Capsaicin was applied to the sciatic nerve and Evans Blue was injected
immediately after capsaicin. Ipsilateral and contralateral paw images were captured 45 minutes after capsaicin treatment.
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direct application of capsaicin to the sciatic nerve. Tak-
ing our findings together, the most parsimonious expla-
nation is that discharge activity in TRPV1-expressing C-
fibers triggers a cascade of events which, after many
hours, leads to an increase in BSCB and BBB
permeability. Our findings thus reveal a previously
unknown function of TRPV1-expressing C-fibers.
This function of these afferents to cause opening of
the BSCB was unanticipated as peripheral neurogenic
plasma extravasation, which is also initiated by TRPV1-
expressing C-fibers, develops rapidly upon electrical
Figure 5 Increased BSCB permeability extends throughout the spinal cord.A :l e f tp a n e l ,r e p r e s e n t a t i v es p i n a lc o r df r o mn a ï v er a t s ,r a t s2 4
hours post C-fiber stimulation or rats with lidocaine block before C-fiber stimulation. Middle and right panels, C-fiber stimulation (middle) or
local application of capsaicin onto sciatic nerve (right) increases contralateral spinal cord Evans Blue permeability 24 hours post treatment. B:
Increased permeability to Evans Blue in the lumbar spinal cord contralateral to CCI (left panel) or SNI (middle) and in thoracic spinal cord (right).
Upper picture: representative spinal cord and brain from naïve rats, or rats 24 hours post PNI. Data are presented as mean ± SEM; *P < 0.05, **p
< 0.01, **P < 0.001 compared to respective naïve groups, n = 6-9 per group.
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within tens of seconds of the start of C fiber stimulation
[20,23]. By contrast, BSCB permeability has been found
to not increase during or within minutes after C fiber
stimulation [13] or with intravenous administration of
capsaicin [24]. Thus, the onset of the effect of TRPV1-
expressing afferents on vascular permeability in periph-
eral tissues is dramatically different than that of the
effect of these fibers on vascular permeability in the
CNS. A second major difference between the effects of
TRPV1-afferents on peripheral versus CNS vascular per-
meability is the duration of the increase: peripheral
plasma extravasation ends within minutes of terminating
electrical C-fiber stimulation [23], whereas the increase
in BSCB permeability persists for days after the stimula-
tion. A third difference is the localization of the increase
in vascular permeability: plasma extravasation in the
periphery is highly localized to the territory innervated
by the nerve that is stimulated [25] whereas the increase
in permeability in the CNS is evoked far beyond the
anatomical distribution of the central terminals, occur-
ring throughout the spinal cord. These major differences
imply that, beyond being initiated by TRPV1-expressing
C-fibers, the mechanisms for the sensory neuron-evoked
increase in vascular permeability in the CNS are highly
divergent from those producing plasma extravasation in
the periphery.
Because the increase in BSCB permeability is delayed
many hours after electrical C-fiber stimulation and the
increase is not prevented by applying lidocaine to the
nerve immediately after the stimulation, we infer that
the activity evoked during the stimulation acts to trigger
a cascade of events that culminates in the opening of
the barrier. It is conceivable that the cascade may
include transcription of critical genes and translation of
the relevant gene products that act as mediators. In
addition, or alternatively, to increased production of cer-
tain gene products, key elements of the BBB might
become reduced, and in preliminary experiments we
have found a decrease in the level of aquaporin-4, a
component of the BBB, preceding the increase in per-
meability [19]. Given the widespread increase in vascular
permeability in the CNS, a possible scenario may be that
the cascade of events involves the production and
release of a humoral mediator, or mediators, that act on
the cellular and/or intercellular elements that maintain
the intact barrier. Alternatively, there could be rostral
spread of BSCB permeability fr o ma ni n i t i a t i o ns i t ei n
the lumbar dorsal horn or central release of diffusible
mediator(s) that circulate within the cerebrospinal fluid.
Or, the increased permeability might be caused by
synaptically released mediators from neuronal pathways
having widespread projections, such as those from
brainstem or hypothalamic regions.
The increase in BSCB permeability might contribute
to the development of pain hypersensitivity after PNI.
Increased permeability may facilitate the entry of circu-
lating cells such as monocytes [15] and T cells [17] that
home to the dorsal horn near the site of termination of
the central endings of injured primary afferents.
Increased BSCB permeability could also allow entry of
soluble factors that are normally excluded but that
could contribute to pain hypersensitivity in the dorsal
horn. For example, fibronectin is known to cross the
opened BBB [26] and this is known to stimulate P2X4R
expression in microglia [27], and this increase in P2X4
is critical for mechanical hypersensitivity after PNI
[28,29]. Also, matrix metalloproteinases (MMPs) have
been implicated in opening the BBB [30], and MMPs in
the dorsal horn are critical for pain hypersensitivity after
PNI [31,32]. However, the PNI-induced increase in BBB
permeability is not sufficient on its own to cause pain
hypersensitivity because permeability is increased
throughout the spinal cord whereas pain hypersensitivity
is typically restricted to the region near the nerve injury.
Our finding that the PNI-induced increase in BSCB
permeability began within 24 hours and the permeability
returning to the basal level by 7 days after PNI, is at
earlier time points than a previous report using transec-
tion of the L4 spinal nerve [18]. It was found that L4
n e r v ei n j u r yc a u s e da ne n d o g e n o u sa l b u m i na c c u m u l a -
tion at time points of one to ten weeks after the transec-
tion. The accumulation observed at those time points
may reflect albumin that entered during the period of
opening that we have discovered here. The recovery of
BSCB integrity appears to be due to a gradual loss of
the signals that are driving the opening, rather than to
resistance of the BSCB to sustained signals to open,
because we found here that the permeability increased
upon a second nerve injury 7 days after the first. Thus,
while the BSCB is only open for several days after nerve
injury, repeated nerve injury may re-open the BSCB
after it has recovered.
Traumatic and ischemic injuries to the CNS are well-
known to cause localized disruption of the BBB which is
considered critical to the pathophysiology [1,33,34].
With the stimuli used presently – PNI, electrical C-fiber
stimulation or capsaicin applied to the nerve – there is
no direct injury to areas where the BSCB and BBB per-
meability is increased. Thus, CNS injury cannot account
for the increases in BSCB and BBB permeability we have
found presently.
Our findings open up the possibility that PNI and acti-
vating TRPV1-expressing primary afferents may cause
increased BSCB and BBB permeability in humans. If this
is found to be the case, then there are several potential
clinical implications of our findings. First, the BSCB and
BBB would be much more permeable in situations of
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when there is nerve damage. From this, one may expect
that the pharmacokinetics of systemically administered
drugs may be altered and the penetration into CNS
might be enhanced. This enhanced drug penetration
might increase the potency of agents where BBB perme-
ability is limiting, but might also increase centrally-
mediated side effects. A second potential clinical implica-
tion is that our findings may point to development of
approaches to purposefully open the BBB in order to
facilitate entry of drugs that normally have limited access
to central targets. While it is unlikely that direct nerve
injury would be used therapeutically, it is conceivable
that short-duration C-fiber stimulation, done under gen-
eral anaesthesia as in the studies here in rats, might be
tolerated. However, by far the best approach would be
through ascertaining the mediator or mediators involved
in the afferent-induced opening of the BBB and to then
develop treatments based on mimicking, in a safe way,
the mechanism. A third possibility is that widespread
opening of the BBB caused by PNI or activation of
TRPV1-expressing C-fibers might contribute to the so-
called ‘sickness syndrome’ [35] that follows injury. A
final, and much more speculative, possibility to consider
pertains to non-traumatic, non-ischemic disorders where
disruption of the BBB appears critical for the pathophy-
siology, such as demyelinating, neuroimmune or neuro-
degenerative disorders. Our findings raise the possibility
that in some such diseases activity of TRPV1-expressing
C-fibers may contribute to the BBB disruption.
Conclusions
I ns u m m a r y ,w eh a v ed i s c o v e r e dt h a tp e r i p h e r a ln e r v e
injury and activation of TRPV1-expressing C-fibers
causes extensive opening of the BSCB and BBB. The
onset of the opening is delayed by many hours after
the stimulus and persists for several days. The opening
of the BSCB may contribute to the pathophysiology of
neuropathic pain hypersensitivity by creating a permis-
sive environment for recruitment and infiltration of
circulating immune cells into the spinal cord parench-
yma. Given the widespread effect on vascular perme-
ability in the CNS it is possible that activating the
sensory nerves causes the release of a circulating fac-
tor, or factors, that causes breakdown of the barrier.
Our findings have a number of potential clinical impli-
cations for situations where there is activation of
TPRV1-expressing C-fibers, such as trauma or other
noxious peripheral stimuli.
Methods
Animals
All animals were used in accordance with the guidelines
of the Canadian Council on Animal Care. All protocols
were approved by the Animal Care Committee of the
Hospital for Sick Children. For all experiments male
250-300 g Sprague-Dawley (Charles River) were used.
Peripheral Nerve injury models
Spared nerve injury (SNI) was performed as described
previously [36]. Briefly, rats were anaesthetized by iso-
fluorane inhalation and the left sciatic nerve exposed
under aseptic conditions. The distal trifurcation of the
sciatic nerve was identified and the tibial and common
peroneal branches ligated and cut, leaving the sural
branch intact. The wound was sutured closed and the
animals allowed to recover and returned to their hous-
ing. Chronic constriction injury (CCI) was performed as
described previously [37]. A polyethylene cuff (PE-60, 2
mm in length) was placed around the exposed left scia-
tic nerve and the wound closed as above. Sham sur-
geries, exposure of the sciatic nerve only, were also
performed. To assess the effect of sequential nerve
injury on the permeability of the BSCB, CCI was per-
formed on the left sciatic nerve followed by a further
CCI on the right nerve 7 days later.
Electrical stimulation of sciatic nerve
The sciatic nerve was isolated as described above and a
bipolar stimulating hook electrode was used for electrical
stimulation. The stimulation parameters for C-fiber strength
stimulation were: 5 min train duration, 500 μsec stimulus
pulse duration, 10 Hz, 10 mA. The stimulation parameters
for A-fiber strength stimulation were: 5 min train duration,
150 μsec stimulus pulse duration, 10 Hz, 1 mA.
Lidocaine block
0.1 ml of 2% lidocaine (Novocol Pharmaceutical,
Canada) was applied topically to the sciatic nerve for 30
minutes before nerve injury or C-fiber stimulation. The
efficacy of local lidocaine block was confirmed by lack
of peripheral plasma extravasations 45 minutes after
C-fiber stimulation.
Capsaicin stimulation
Capsaicin (1% in Ethanol: Tween 80: saline 1:1:8, Sigma-
Aldrich) or vehicle was applied to the sciatic nerve.
Evans Blue assay
Blood spinal cord permeability was determined by Evans
Blue extravasation into the spinal cord. Evan’sb l u ed y e
(2%, 4 ml/kg) was infused through the jugular vein of
anaesthetized rats. After 45 minutes animals were per-
fused with PBS. The spinal cord and supraspinal tissues
were immediately dissected and dura mater removed.
The lumbar spinal cord (L4-6), and middle thoracic
cord were further dissected. Tissue was incubated in
600 μl of formamide (Sigma-Aldrich) at 60C for 72 h.
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trophotometry at 620 nm.
Horseradish peroxidise assay
BSCB permeability was further assayed using a horse-
radish peroxidise (HRP) assay. HRP (3 mg/kg) was
infused through the jugular vein of anaesthetized ani-
mals. 45 minutes later animals were perfused transcar-
dially with 10% formalin solution. Following post-
fixation and sucrose cryoprotection, spinal cord sections
(50 μm) were cut on a microtome. Sections were incu-
bated in cy3-labelled tyramide solution (Perkin Elmer)
for 7 minutes to measure HRP activity. Resulting fluor-
escence images were captured and integrated pixel den-
sity measured using Volocity software.
Statistics
Evan’s Blue concentration was assessed across all groups
using one way ANOVA and Newman-Keuls post-hoc
multiple comparisons. Where appropriate, naïve and
experimental groups were compared using t-tests.
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